Results of the ALLHAT Trial: Is the Debate About Initial Antihypertensive Drug Therapy Over?
Author:
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-6175.2003.02259.x/fullpdf
Reference36 articles.
1. Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2. Original Papers
3. The influence of non-beta-blocking drugs on the lipid profile: Are diuretics outclassed as initial therapy for hypertension?
4. Alternatives to traditional antihypertensive therapy.
5. New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diuretics;Comprehensive Hypertension;2007
2. Determinants for the adoption of angiotensin II receptor blockers by general practitioners;Social Science & Medicine;2006-12
3. Does comorbidity explain trends in prescribing of newer antihypertensive agents?;Journal of Hypertension;2004-11
4. Managing High‐Risk Patients With Hypertension: Focus on the Renin‐Angiotensin System;The Journal of Clinical Hypertension;2004-09
5. ALLHAT and ANBP2: What Have We Learned From Recent Mega‐Trials?;The American Journal of Geriatric Cardiology;2003-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3